You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study

Article metrics

Article menu

Download PDFPDF

XML
Immune cell therapies and immune cell engineering
Original research
Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study

 

Online download statistics by month:

Online download statistics by month: September 2020 to February 2026

AbstractFullPdf
Sep 2020329329149
Oct 2020264264140
Nov 202010010055
Dec 2020444426
Jan 202110310342
Feb 2021939331
Mar 202111911960
Apr 2021717144
May 2021515134
Jun 2021585832
Jul 2021616139
Aug 2021626249
Sep 2021666658
Oct 2021717150
Nov 2021565756
Dec 2021636534
Jan 2022727758
Feb 2022535323
Mar 2022848443
Apr 2022697142
May 2022828542
Jun 2022888954
Jul 2022556024
Aug 2022818144
Sep 2022787851
Oct 202210310646
Nov 2022939441
Dec 2022606033
Jan 2023434329
Feb 2023636423
Mar 2023555634
Apr 2023424317
May 2023262613
Jun 2023232316
Jul 2023323221
Aug 2023282812
Sep 2023353510
Oct 2023272716
Nov 2023353521
Dec 2023494927
Jan 2024293030
Feb 2024363623
Mar 2024414296
Apr 2024313119
May 2024515337
Jun 2024525344
Jul 2024686947
Aug 2024232313
Sep 2024323323
Oct 2024393923
Nov 2024383919
Dec 2024535339
Jan 2025424232
Feb 2025515133
Mar 2025454530
Apr 2025535326
May 2025464636
Jun 2025323218
Jul 2025001
Jan 2026110
Feb 2026110
Total375137852228